Partner Content Partner Content Jayne Hurrell joins OPEN Access Consulting as Director of Gl... Jayne Hurrell joins OPEN Access Consulting as Director
Partner Content Partner Content Matt De Gruchy joins Reynolds Mackenzie as new agency CEO Matt De Gruchy joins Reynolds Mackenzie as new CEO
News Trump drug price plan attacks 'global freeloaders' Donald Trump made great play about his plans to take on big pharma during his presidential campaign – but his plan to cut drug prices has pleased investors and angered those calling for tou
News NICE asks EUSA pharma to drop price of neuroblastoma drug NICE calls for price cut before possible CDF funding
News Report warns of UK's rare disease 'postcode lottery' There is still a ‘postcode lottery’ for patients getting access to vital rare disease treatments in the UK, according to a new report.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.